| Dr Janardhan Mydam, MD | |
|
3249 Oak Park Ave, Berwyn, IL 60402-3429 | |
| (708) 783-2226 | |
| Not Available |
| Full Name | Dr Janardhan Mydam |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 3249 Oak Park Ave, Berwyn, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396024972 | NPI | - | NPPES |
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists at the University Of Utah School Of Medicine.
Nektar Therapeutics today announced that the first subjects were dosed in a new Phase 1 clinical study to evaluate NKTR-181, the company's next-generation opioid analgesic candidate. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and serious CNS side effects associated with currently available opioid therapies.
Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").
The age a woman begins menstruation is associated with having high blood pressure later in her life, according to a team of researchers at the University of Georgia.
Mergers between Catholic and secular hospitals could mean wider restriction of abortion, even as lawmakers in many states consider tighter regulation or bans on the procedure.
› Verified 2 days ago
| Entity Name | Cook County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists at the University Of Utah School Of Medicine.
Nektar Therapeutics today announced that the first subjects were dosed in a new Phase 1 clinical study to evaluate NKTR-181, the company's next-generation opioid analgesic candidate. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and serious CNS side effects associated with currently available opioid therapies.
Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").
The age a woman begins menstruation is associated with having high blood pressure later in her life, according to a team of researchers at the University of Georgia.
Mergers between Catholic and secular hospitals could mean wider restriction of abortion, even as lawmakers in many states consider tighter regulation or bans on the procedure.
› Verified 2 days ago
| Entity Name | Gottlieb Community Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013415603 PECOS PAC ID: 3375442999 Enrollment ID: O20180420000980 |
News Archive
SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists at the University Of Utah School Of Medicine.
Nektar Therapeutics today announced that the first subjects were dosed in a new Phase 1 clinical study to evaluate NKTR-181, the company's next-generation opioid analgesic candidate. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and serious CNS side effects associated with currently available opioid therapies.
Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").
The age a woman begins menstruation is associated with having high blood pressure later in her life, according to a team of researchers at the University of Georgia.
Mergers between Catholic and secular hospitals could mean wider restriction of abortion, even as lawmakers in many states consider tighter regulation or bans on the procedure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Janardhan Mydam, MD 3901 Beaubien St, 3t72, Detroit, MI 48201-2119 Ph: (313) 745-5533 | Dr Janardhan Mydam, MD 3249 Oak Park Ave, Berwyn, IL 60402-3429 Ph: (708) 783-2226 |
News Archive
SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists at the University Of Utah School Of Medicine.
Nektar Therapeutics today announced that the first subjects were dosed in a new Phase 1 clinical study to evaluate NKTR-181, the company's next-generation opioid analgesic candidate. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and serious CNS side effects associated with currently available opioid therapies.
Quest PharmaTech Inc. ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced that it has acquired a pipeline of late-stage immunotherapy product candidates from Paladin Labs Inc. ("Paladin").
The age a woman begins menstruation is associated with having high blood pressure later in her life, according to a team of researchers at the University of Georgia.
Mergers between Catholic and secular hospitals could mean wider restriction of abortion, even as lawmakers in many states consider tighter regulation or bans on the procedure.
› Verified 2 days ago
Haris Aleem, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3249 Oak Park Ave, Berwyn, IL 60402 Phone: 708-783-9100 | |
Udochukwu O Asonye, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 3249 Oak Park Ave, Berwyn, IL 60402 Phone: 708-783-2226 | |
Aijaz Walji, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 3249 Oak Park Ave, Berwyn, IL 60402 Phone: 708-783-2226 | |
Tonia Ann Gooden, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3231 Euclid Ave, Berwyn, IL 60402 Phone: 708-783-3400 |